clinical trial · NCT04812860
A Study to Evaluate the Efficacy and Safety of HR18042 Tablets in the Treatment of Postoperative Pain of Impacted Tooth.
Jiangsu HengRui Medicine Co., Ltd.·phase2·completed·n = 187
Moderate to Severe Acute PainHR18042HR18042HR18042Tramadol hydrochloride ERPlacebo
brief summary
The purpose of this study was to evaluate the Efficacy and safety of HR18042 tablets for the Treatment of Post-surgical Pain After extraction of impacted tooth, find the optimal dose.
started
Dec 8, 2020
primary completion
Jan 25, 2021
completion
Jan 25, 2021
last updated
Jun 22, 2025
official title
A Multicenter,Randomized, Double-blind, Dose Ranging , Active- and Placebo-controlled, Parallel Groups, Phase II Clinical Trial to Evaluate the Efficacy and Safety of HR18042 Tablets for the Treatment of Postoperative Pain of Impacted Tooth.
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol